← SynDRA
TANZISERTIB
SynDRA canonical compound SYN0028711 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | JNK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAPK8 INHIBITOR
- c-Jun N-terminal kinase 1 inhibitor
- MAPK9 INHIBITOR
- c-Jun N-terminal kinase 2 inhibitor
- MAPK10 INHIBITOR
- c-Jun N-terminal kinase 3 inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- MAPK1
- SIK3
- MAPK3
- MAPKAPK2
- MYLK
- LIMK2
- LIMK1
- GAK
- ERN1
- EGFR
- MAPK14
- ULK1
- NTRK3
- PIK3CB
- PIK3CA
- PIK3C2G
- PIK3C2B
- PI4KB
- PHKG2
- PHKG1
- PFKP
- PEBP1
- PDXK
- VRK2
- PDPK1
- PDGFRB
- PDGFRA
- PASK
- PAK6
- PAK4
- PAK3
- PAK2
- PAK1
- PAICS
- OXSR1
- OPA1
- OGG1
- NUAK2
- PIK3CD
- PIK3CG
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- CC-930
- JNK-930
- JNK930
- CC 930
- UNII-M5O06306UO
- CHEMBL1950289
- M5O06306UO
- CC930
- Trans-4-({9-[(3s)-Tetrahydrofuran-3-Yl]-8-[(2,4,6-Trifluorophenyl)amino]-9h-Purin-2-Yl}amino)cyclohexanol
- Tanzisertib [USAN:INN]
- 3tti
- trans-4-((9-((3S)-Tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)cyclohexanol
- Tanzisertib (USAN)
- CC-930(Tanzisertib)
- SCHEMBL2133061
- SCHEMBL4760419
- SCHEMBL2133055
- GTPL9836
- SCHEMBL8082102
- SCHEMBL15589918
- CHEMBL1950305
- SCHEMBL10179476
- MolPort-044-562-358
- RefChem:918157
- Tanzisertib [USAN]
- JNK 930
- C21H23F3N6O2
- JNK-930; JNKI-1
- MFCD23160040
- TANZISERTIB [INN]
- CC-930(Tanzisertib)?
- orb1308483
- SCHEMBL2138755
- SCHEMBL2138766
- SCHEMBL2138776
- SCHEMBL2604921
- GLXC-10800
- EX-A3115
Look up TANZISERTIB in the interactive SynDRA portal →